The POC (point-of-care) diagnostics market stands at about $18.8 billion globally, according to recent market trends, and is expected to grow by a third to $24.1 billion this year and projected to explode by 2024 to $46.7 billion. The main driver for these highly optimistic forecasts is the surge in healthcare technology demand brought on by the
Nueva tecnología financiada por DARPA promete diagnosticar COVID-19 a través de un biochip implantable
Una nueva herramienta de diagnóstico de ARNm desarrollada en la Universidad de Stanford y financiada por BARDA y DARPA está acercando la tecnología de biochips implantables a la realidad.